Viewing Study NCT02818920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-03-11 @ 4:30 PM
Study NCT ID: NCT02818920
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2016-06-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Neoadjuvant Pembrolizumab
Sponsor: Neal Ready MD PhD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Neoadjuvant View
None Tumor Infiltrating Lymphocytes (TILs) View